He spent eight years at LifeLabs, serving as the COO from 2017 to 2019, and successfully led the integration of two acquired competitors. Pierre has a proven track record for growing and transforming healthcare companies. I look forward to working with the leadership team to ensure strategic expansion of our operating model for clinical care and clinical research in psychedelic medicine." Pierre Bou-Mansour said, "Novamind's Cedar Psychiatry clinics and Cedar Clinical Research sites are both well-positioned to scale as regulated access to psychedelic medicine continues to expand rapidly in jurisdictions around the world. In this role, Bou-Mansour successfully led the expansion of Public Health Ontario's testing capacity for the COVID-19 response. Most recently, he served as the Chief Laboratory Operations Officer of Public Health Ontario, serving Canada's largest province with over 14 million residents. Bou-Mansour will assume responsibility for ensuring operational excellence as Novamind develops its network of clinics, retreats, and research sites in 2021 and beyond.Īn accomplished senior executive and leader, Pierre brings a wealth of experience managing large and complex healthcare organizations. TORONTO, ON / ACCESSWIRE / Janu/ Novamind Inc., (CSE:NM) ("Novamind" or the "Company") a mental health company specialized in psychedelic medicine, announces the expansion of its leadership team with the appointment of Pierre Bou-Mansour, P.Eng., to the role of Chief Operating Officer. ![]() Pierre Bou-Mansour is former COO of LifeLabs, one of Canada's largest medical service companies
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |